MedAptus® today announced that Children’s National Health System has completed deployment of the company’s Pro and Tech solutions across its numerous outpatient care locations. Read Full Release
Boston Millennia Partners is pleased to announce that St. Jude Medical (NYSE: STJ) has acquired the remaining 81 percent of CardioMEMS, Inc. it does not own for $375 million dollars. Read Full Release
With the receipt of Hart-Scott-Rodino clearance, the previously announced acquisition of Precision Dermatology by Valeant Pharmaceuticals International, Inc. for $500 million, closed July 7, 2014. Read Full Release
First Coast Cardiovascular Institute (FCCI) has successfully implemented MedAptus’ Professional Charge Capture application and is experiencing significant improvement in efficiency. FCCI chose MedAptus based on functionality and strong track record of success in multi-specialty environment. Read Full Release
MedAptus has entered into a strategic marketing agreement with BESLER Consulting, a leading provider of comprehensive revenue integrity services to healthcare organizations. Under the agreement, MedAptus and BESLER will promote each other’s healthcare services to their clients. Read Full Release
Methodist Healthcare has implemented Medaptus’ Professional Charge Capture (Pro) solution to re-engineer paper-based processes for inpatient coding and billing. Methodist chose the MedAptus software based on ease-of-use, support for team care and robust real-time reconciliation capabilities. Read Full Release
MedAptus® announces that it has released a Risk Severity Toolkit to help provider groups measure and manage the disease burden of patients covered under risk-based contracts. Read Full Release
PAREXEL International Second Quarter Fiscal Year 2014 Results were announced and for the three months ended December 31, 2013 consolidated service revenue increased by 15.4% to $487.1 million. Read Full Release
Odyssey Logistics & Technology, a global supply chain logistics services provider, announced achieving double-digit, year-over-year growth of 32% in 2013. Read Full Release
MedAptus® today announced that its Professional Charge Capture (Pro) solution has been named the Category Leader in the Mobile Data Systems segment in the “2013 Best in KLAS: Software & Services” report, marking the fourth consecutive year that MedAptus has received the distinction. Read Full Release
Onset Dermatologics, a PreCision Dermatology company and a leader in developing and commercializing prescription products for improving skin health, today announced the acquisition of Clindagel® from Galderma Laboratories. Read Full Release
Ryan Secan, MD, MPH, Chief Medical Officer of MedAptus, Inc., a Boston Millennia portfolio company, was published on HIStalk for his comments on product development in health care technology. Read Full Release
Histogenics Corp. announced the addition of Stephen Kennedy as Senior Vice President of Manufacturing, Operations, and Supply Chain, and Vladimir Scerbin as Vice President of Clinical Affairs. Read Full Release
PAREXEL International Corp. (NASDAQ: PRXL) reported financial results for the fourth quarter and Fiscal Year 2013. For the three months ended June 30, 2013 consolidated service revenue increased by 18% to $463.1 million compared with $392.6 million in the prior year period.
Read Full Release
PHT Corp., has named software industry veteran executive, Steve Rosenberg, Chief Operating Officer. Steve brings over 30 years of experience in operations, most recently as Vice President of Software and Services, Health Sciences Global Business Unit (HSGBU) at Oracle Corporation. Read Full Release
Histogenics Corp. has announced the appointment of Peter Greenleaf to Chief Executive Officer. Mr. Greenleaf brings over 20 years of experience in the biotechnology industry, most recently as President of MedImmune, the worldwide biologics arm of AstraZeneca. Read Full Release
Collegium Pharmaceutical was featured in a Wall Street Journal article discussing the innovative technologies being developed in the painkiller market to make drugs more abuse-deterrent. Read Full Release
